RNS OUT with prospectus15 Nov 2022 07:27
If I'm reading it right it looks like our shares will have a value of .3, which is less than the .47 that was forecast but we all know markets and events have changed significantly since then.
UK SPAC Chairman, Peter Jay commented: "All stakeholders of both UK SPAC and Hellenic realise that the last 18 months have been challenging and, at times difficult. However, with the announcement today of the first successful UK listing of a medical cannabis grower, all our efforts have been rewarded. Having had a very long period of working alongside the Hellenic team and getting to know them and to understand their business, we believe that the company that was formerly Mountfield Group is now in very good hands and has exciting prospects."
GLA